News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
583,523 Results
Type
Article (20731)
Company Profile (321)
Press Release (562550)
Multimedia
Podcasts (117)
Webinars (16)
Section
Business (194278)
Career Advice (434)
Deals (29861)
Drug Delivery (59)
Drug Development (71252)
Employer Resources (40)
FDA (12247)
Job Trends (10558)
News (285018)
Policy (22150)
Tag
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (1240)
Accelerated approval (44)
ADA (38)
Adcomms (16)
Allergies (149)
Alliances (41159)
ALS (217)
Alzheimer's disease (1517)
Antibody-drug conjugate (ADC) (563)
Approvals (12870)
Artificial intelligence (596)
ASCO (273)
Autoimmune disease (362)
Automation (37)
Bankruptcy (302)
Best Places to Work (8506)
BIO (65)
Biologics (11)
BIOSECURE Act (6)
Biosimilars (184)
BioSpace Insights (85)
Biotechnology (227)
Bispecific (1)
Bladder cancer (178)
Brain cancer (67)
Breast cancer (700)
Cancer (5680)
Cardiovascular disease (419)
Career advice (374)
Career pathing (14)
CAR-T (336)
CDC (8)
CDMO (99)
Celiac Disease (1)
Cell therapy (911)
Cervical cancer (45)
Clinical research (63628)
Collaboration (2083)
Commercialization (7)
Company closure (4)
Compensation (1612)
Complete response letters (76)
COVID-19 (1447)
CRISPR (126)
C-suite (1209)
Cystic fibrosis (146)
Data (8153)
Denatured (27)
Depression (165)
Dermatology (103)
Diabetes (508)
Diagnostics (4854)
Digital health (46)
Diversity (6)
Diversity, equity & inclusion (12)
Drug discovery (362)
Drug pricing (59)
Drug shortages (5)
Duchenne muscular dystrophy (330)
Earnings (80708)
Editorial (37)
Employer branding (6)
Employer resources (38)
Events (103723)
Executive appointments (1009)
FDA (15874)
Fibrodysplasia Ossificans Progressiva (10)
Fragile X (1)
Friedreich's ataxia (25)
Frontotemporal dementia (36)
Funding (1696)
Gene editing (264)
Generative AI (44)
Gene therapy (740)
GLP-1 (698)
Government (1768)
Grass and pollen (4)
Guidances (335)
Healthcare (12070)
Hematology (147)
HIV (70)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (109)
Immunology and inflammation (287)
Immuno-oncology (107)
Indications (210)
Infectious disease (1711)
Inflammatory bowel disease (206)
Inflation Reduction Act (12)
Influenza (95)
Intellectual property (315)
Interviews (58)
IPO (14371)
IRA (13)
Job creations (2423)
Job search strategy (337)
JPM (41)
Kidney cancer (20)
Labor market (38)
Layoffs (309)
Leadership (15)
Legal (5658)
Licensing (24)
Liver cancer (68)
Longevity (33)
Lung cancer (780)
Lymphoma (407)
Machine learning (47)
Management (10)
Manufacturing (872)
Marketing (12)
MASH (191)
Medical affairs (3)
Medical device (9931)
Medtech (10106)
Mergers & acquisitions (16733)
Metabolic disorders (1260)
mRNA (202)
Multiple sclerosis (161)
Multispecific (1)
NASH (14)
Neurodegenerative disease (450)
Neuropsychiatric disorders (105)
Neuroscience (3074)
Neurotech (1)
NextGen: Class of 2026 (4131)
Non-profit (1519)
Now hiring (43)
Obesity (527)
Opinion (157)
Ovarian cancer (228)
Pain (237)
Pancreatic cancer (328)
Parkinson's disease (380)
Partnered (22)
Patents (609)
Patient advocacy (1)
Patient recruitment (812)
Peanut (55)
People (49690)
Peptides (4)
Pharmaceutical (50)
Pharmacy benefit managers (14)
Phase 1 (21018)
Phase 2 (28702)
Phase 3 (19514)
Pipeline (10048)
Policy (117)
Postmarket research (1893)
Preclinical (8968)
Press Release (52)
Prostate cancer (296)
Psychedelics (76)
Radiopharmaceuticals (355)
Rare diseases (1142)
Real estate (3779)
Recruiting (14)
Regulatory (19609)
Reports (35)
Research institute (1330)
Resumes & cover letters (60)
Rett syndrome (50)
RNA editing (32)
RSV (57)
Schizophrenia (177)
Series A (313)
Series B (225)
Service/supplier (5)
Sickle cell disease (119)
Special edition (21)
Spinal muscular atrophy (144)
Sponsored (22)
Startups (3121)
State (1)
Stomach cancer (8)
Supply chain (73)
Tariffs (19)
The Weekly (88)
Vaccines (588)
Venture capital (109)
Weight loss (269)
Women's health (107)
Worklife (3)
Date
Today (133)
Last 7 days (523)
Last 30 days (1998)
Last 365 days (25875)
2026 (18085)
2025 (25762)
2024 (30028)
2023 (33976)
2022 (43313)
2021 (45731)
2020 (40883)
2019 (29829)
2018 (22460)
2017 (24179)
2016 (22652)
2015 (28870)
2014 (24869)
2013 (20676)
2012 (22487)
2011 (22747)
2010 (22421)
Location
Africa (337)
Alabama (94)
Alaska (3)
Arizona (347)
Arkansas (14)
Asia (29068)
Australia (4470)
California (14068)
Canada (3814)
China (1393)
Colorado (569)
Connecticut (549)
Delaware (377)
Europe (54097)
Florida (2057)
Georgia (428)
Hawaii (4)
Idaho (47)
Illinois (954)
India (88)
Indiana (449)
Iowa (19)
Japan (559)
Kansas (116)
Kentucky (38)
Louisiana (42)
Maine (37)
Maryland (1483)
Massachusetts (10171)
Michigan (325)
Minnesota (640)
Mississippi (5)
Missouri (96)
Montana (32)
Nebraska (14)
Nevada (137)
New Hampshire (75)
New Jersey (3266)
New Mexico (19)
New York (3451)
North Carolina (1721)
North Dakota (9)
Northern California (7222)
Ohio (354)
Oklahoma (15)
Oregon (35)
Pennsylvania (2722)
Puerto Rico (24)
Rhode Island (38)
South America (527)
South Carolina (80)
South Dakota (1)
Southern California (5612)
Tennessee (151)
Texas (2256)
United States (47516)
Utah (408)
Vermont (1)
Virginia (254)
Washington D.C. (51)
Washington State (1135)
West Virginia (2)
Wisconsin (111)
Wyoming (1)
583,523 Results for "mabwell therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ERS 2026 | Mabwell Presents Phase Ib/IIa Clinical Results of Anti-ST2 Monoclonal Antibody 9MW1911 in COPD Patients
September 4, 2026
·
5 min read
Press Releases
Mabwell’s 9MW5211 Receives IND Clearance from NMPA for Inflammatory Bowel Disease
June 5, 2026
·
5 min read
Press Releases
Mabwell Announces NMPA Approval of Supplemental Application for Additional Indications of MAIWEIJIAN (Denosumab Injection)
May 21, 2026
·
5 min read
Press Releases
World’s First | Mabwell’s 9MW5211 Receives FDA Clearance for Clinical Trial Application
May 10, 2026
·
5 min read
Press Releases
Mabwell Presents Clinical Results of Nectin-4-Targeting ADC 9MW2821 at 2026 ESMO Gynaecological Cancers Congress
June 19, 2026
·
6 min read
Press Releases
Mabwell Receives IND Clearance from NMPA for LILRB4/CD3-targeting TCE Bispecific Antibody 6MW5311
June 24, 2026
·
6 min read
Press Releases
ESMO 2026 | Mabwell to Present Latest Clinical Data on Nectin-4-targeting ADC 9MW2821 for Triple Negative Breast Cancer in Oral Presentation
July 21, 2026
·
3 min read
Press Releases
Mabwell Announces Acceptance of Supplemental Biologics License Application by NMPA for MAIWEIJIAN (Denosumab)
April 16, 2026
·
5 min read
Press Releases
Mabwell Establishes a Licensing and Commercialization Agreement for Denosumab Biosimilars in Malaysian Market
April 16, 2026
·
4 min read
Press Releases
Mabwell Announces Latest Clinical Data on 9MW2821 to Be Presented at 2026 ASCO Annual Meeting as Oral and Poster Presentations
May 22, 2026
·
5 min read
1 of 58,353
Next
